Title: | Cholesterol Levels Are Associated with 30-day Mortality from Ischemic Stroke in Dialysis Patients |
Authors: | B.-S. Yip Liu C.-H. Yen T.-H. JIANN-SHING JENG Hsu S.-P. Chen C.-H. Lien L.-M. Lin R.-T. Chen A.-C. Lin H.-J. Chi H.-Y. Lai T.-C. Sun Y. Lee S.-P. Sung S.-F. Chen P.-L. Lee J.-T. Chiang T.-R. Lin S.-K. Muo C.-H. Ma H. Wen C.-P. Sung F.-C. Hsu C.Y. Tsai C.-H. Huang W.-S. Lu C.-T. Tsai T.-C. Tseng C.-H. Lin K.-H. Shyn W.-C. Yang Y.-W. Liu Y.-L. Cho D.-Y. Chen C.-C. SUNG-CHUN TANG LI-KAI TSAI SHIN-JOE YEH Chen H.-J. Chang C.-S. Kuo H.-C. Lee L.-H. Tsui H.-W. Tsou J.-C. Wang Y.-T. Tai Y.-C. Tsai K.-C. Chen Y.-W. Lu K. Liliang P.-C. Tsai Y.-T. Liang C.-L. Wang K.-W. Wang H.-K. Chen J.-S. Chen P.-Y. Chye C.-L. Tzeng W.-J. Wu P.-H. Sung P.-S. Hsieh H.-C. Su H.-C. Chiu H.-C. Chen W.-H. Bai C.-H. Huang T.-H. Lau C.-I. Wu Y.-Y. Yeh H.-L. Chang A. Lin C.-H. Yen C.-C. Khor G.-T. Chao A.-C. Lin H.-F. Huang P. Ke D.-S. Chang C.-Y. Yeh P.-S. Lin K.-C. Cheng T.-J. Chou C.-H. Yang C.-M. Shen H.-C. Tsai S.-J. Lu T.-M. Kung S.-L. Lee M.-J. Chou H.-H. Pan C.-H. Chan P.-C. Hsu M.-H. Chang W.-L. Huang Z.-Z. Shoung H.-M. Lo Y.-C. Wang F.-H. Yin J.-H. Wang C.-J. Wang K.-C. Chen L.-M. Denq J.-C. Lu C.-J. Huang C.-C. Chan H.-F. Sun M.-H. Ke L.-Y. Lee Y.-S. Ong C.-T. Wu C.-S. Hsu Y.-C. Su Y.-H. Hung L.-C. Lin J.-C. Hsu Y.-D. Peng G.-S. Hsu C.-H. Lin C.-C. Yen C.-H. Cheng C.-A. Sung Y.-F. Chen Y.-L. Lien M.-T. Liu C.-C. Yang F.-C. Wu Y.-C. Tso A.-C. Lai Y.-H. Chiang C.-I. Tsai C.-K. Liu M.-T. Lin Y.-C. Hsu Y.-C. Lee M.-C. Huang P.-H. Lie S.-K. Liao P.-W. Chen J.-T. Sun M.-C. Lai T.-P. Chen W.-L. Chen Y.-C. Chen T.-C. Wang W.-F. Lee K.-W. Lai C.-H. Shih S.-Y. Chuang C.-S. Chen Y.-Y. Chen C.-M. Su Y.-C. Hsiao C.-L. Yang F.-Y. Liu C.-Y. Chiang H.-L. Lin I.-S. Chien C.-H. Chang Y.-C. Chen P.-K. Chiu P.-Y. Hsiao Y.-J. Fang C.-W. Lee K.-Y. Lin Y.-Y. Li C.-H. Tsai H.-F. Hsieh C.-F. Yang C.-D. Liaw S.-J. Liao H.-C. Wu L.-L. Hsieh L.-P. Lee Y.-H. Chen C.-W. Hsu C.-S. Jhih Y.-J. Zhuang H.-Y. Pan Y.-H. Shih S.-A. Chen C.-I. Sung J.-Y. Weng H.-Y. Teng H.-W. Lee J.-E. Huang C.-S. Chao S.-P. Yuan R.-Y. Sheu J.-J. Yu J.-M. Ho C.-S. Lin T.-C. Yu S.-C. Chen J.-R. Tsai S.-Y. Wei C.-Y. Yang C.-N. Hung C.-H. Shih I. Tseng H.-P. Lin C.-L. Lin H.-C. Chen P.-T. Hu C.-J. Chi N.-F. Chan L. Chern C.-M. Lin C.-J. Wang S.-J. Hsu L.-C. Wong W.-J. Lee I.-H. Yen D.-J. Tsai C.-P. Kwan S.-Y. Soong B.-W. Chen S.-P. Liao K.-K. Lin K.-P. Chen C. Shan D.-E. Fuh J.-L. Wang P.-N. Lee Y.-C. Yu Y.-H. Huang H.-C. Tsai J.-Y. Wu M.-H. Chen S.-C. Chiang S.-Y. Wang C.-Y. Hsu M.-C. Yeh P.-Y. Wang K.-Y. Chen T.-S. Yip P.-K. Wang V. Tsai C.-F. Liu Y.-C. Chen S.-Y. Zhao Z.-H. Wei Z.-P. Wu S.-L. Liu C.-K. Lin R.-H. Chu C.-H. Yan S.-H. Hsiao S.-H. Yip B.-S. Tsai P.-C. Chou P.-C. Kuo T.-M. Chiu Y.-P. Liao Y.-S. Tsai M.-J. Kao H.-Y. |
Issue Date: | 2017 |
Journal Volume: | 26 |
Journal Issue: | 6 |
Start page/Pages: | 1349-1356 |
Source: | Journal of Stroke and Cerebrovascular Diseases |
Abstract: | Background We investigated the impact of serum cholesterol levels on 30-day mortality after ischemic stroke in dialysis patients. Methods From the Taiwan Stroke Registry data, we identified 46,770 ischemic stroke cases, including 1101 dialysis patients and 45,669 nondialysis patients from 2006 to 2013. Results Overall, the 30-day mortality was 1.46-fold greater in the dialysis group than in the nondialysis group (1.75 versus 1.20 per 1000 person-days). The mortality rates were 1.64, .62, 2.82, and 2.23 per 1000 person-days in dialysis patients with serum total cholesterol levels of?<120?mg/dL, 120-159?mg/dL, 160-199?mg/dL, and ?200?mg/dL, respectively. Compared to dialysis patients with serum total cholesterol levels of 120-159?mg/dL, the corresponding adjusted hazard ratios of mortality were 4.20 (95% confidence interval [CI]?=?1.01-17.4), 8.06 (95% CI?=?2.02-32.2), and 6.89 (95% CI?=?1.59-29.8) for those with cholesterol levels of?<120?mg/dL, 160-199?mg/dL, and??200?mg/dL, respectively. Conclusions Dialysis patients with serum total cholesterol levels of??160?mg/dL or?<120?mg/dL on admission are at an elevated hazard of 30-day mortality after ischemic stroke. ? 2017 National Stroke Association |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015790277&doi=10.1016%2fj.jstrokecerebrovasdis.2017.02.007&partnerID=40&md5=f9a86473c618e05b64e9f331171fa34d https://scholars.lib.ntu.edu.tw/handle/123456789/590456 |
ISSN: | 10523057 |
DOI: | 10.1016/j.jstrokecerebrovasdis.2017.02.007 |
SDG/Keyword: | antilipemic agent; cholesterol; hemoglobin; biological marker; cholesterol; adult; aged; Article; atrial fibrillation; body mass; brain ischemia; cholesterol blood level; controlled study; end stage renal disease; female; hemodialysis; hemodialysis patient; hemoglobin blood level; human; major clinical study; male; mortality; National Institutes of Health Stroke Scale; prevalence; priority journal; stroke patient; systolic blood pressure; blood; brain ischemia; cerebrovascular accident; chronic kidney failure; clinical trial; epidemiology; hemodialysis; hospital admission; Kaplan Meier method; middle aged; multicenter study; prognosis; proportional hazards model; register; risk factor; Taiwan; time factor; very elderly; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Cholesterol; Female; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Patient Admission; Prognosis; Proportional Hazards Models; Registries; Renal Dialysis; Risk Factors; Stroke; Taiwan; Time Factors |
Appears in Collections: | 醫學院附設醫院 (臺大醫院)
|